La titulación de RAS altera el estado senescente e influye en el inicio del tumor.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La senescencia oncogénica inducida por RAS (OIS) normalmente suprime los tumores. Sin embargo, una dosis más baja de RAS oncogénico permite el escape inmune, lo que lleva a distintos tipos de carcinoma hepatocelular, revelando un espectro de fenotipos de OIS.
Área De La Ciencia
- Biología molecular
- En el campo de la oncología
- Inmunología
Sus Antecedentes
- La senescencia oncogénica inducida por RAS (OIS) es un mecanismo supresor de tumores durante la premalignancia.
- No se comprende bien el impacto de una dosis más baja de RAS oncogénico en los fenotipos de la EIO y en la iniciación de tumores.
Objetivo Del Estudio
- Investigar el espectro de fenotipos OIS impulsados por las diferentes dosis oncogénicas de RAS.
- Elucidar los mecanismos de evasión inmune y desarrollo tumoral bajo diferentes niveles de estrés oncogénico.
Principales Métodos
- Desarrollo de modelos de escalado de dosis de RAS oncogénico in vitro e in vivo.
- Secuenciación de ARN de una sola célula para analizar las subpoblaciones de hepatocitos.
- Monitoreo de series temporales a resolución de una sola célula para rastrear el desarrollo del tumor.
Principales Resultados
- Se observó un continuo no lineal de fenotipos descendentes con el aumento de la dosis de RAS oncogénico.
- Una dosis más baja de NRAS ((G12V) dio lugar a la formación de hepatocitos inmunoresistentes y tumores.
- Se identificaron dos subtipos distintos de carcinoma hepatocelular (de aparición temprana, agresivo, indiferenciado y de aparición tardía, diferenciado), relacionados con las características progenitoras y las subclases humanas de HCC.
Conclusiones
- La dosis de RAS oncogénico influye críticamente en el espectro de OIS, determinando la función supresora del tumor o el inicio del tumor.
- La comprensión del espectro de OIS basado en la dosis oncogénica concilia los fenotipos de senescencia y iniciación tumoral en la tumorigénesis temprana.
- Este estudio proporciona información sobre la heterogeneidad del desarrollo del carcinoma hepatocelular.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Guanine nucleotide exchange factors or GEF,
GTPase-activating proteins or GAPs, and
Guanine nucleotide-dissociation inhibitors or GDIs.
The GEF activates the GTPase by exchanging the bound-GDP with GTP. The...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...